The prepx study enrolled over 5,000 participants between 2016 and 2018 in victoria, south australia and tasmania. Expanded (prepx) is a new study that will expand the provision of prep to 3,200 victorians who have a high chance of acquiring hiv. Interim analysis from the prepx demonstration study
Prepx trial sponsors:alfred health and the victorian aids council, victorian government start date end date july 26, 2016 march. Prepx is a population level intervention study in victoria, australia in which generic prep will be delivered to 3800 individuals for up to 36 months. Improve your skills with personalized exercises, instant feedback, and comprehensive study resources.
Changes, patterns and predictors of sexually transmitted infections in gay and bisexual men using prep; Participants were at risk of hiv infections and. The vicprep study neared completion as the prepx study commenced. Hiv pre‐exposure prophylaxis (prep), the use of hiv treatment medication by people at risk of hiv to reduce their risk of acquisition, has emerged over recent years as a highly‐effective hiv.
Prep is highly efficacious when.